A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors
Clinical trial NCT02829723 · TERMINATED
Trial details
- NCT number
- NCT02829723
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-21
- Primary completion
- 2022-12-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.